168 related articles for article (PubMed ID: 37404988)
1. Zebrafish thrombosis models according to the location of thrombus formation.
Hwang J; Koun S; Ha Y; Jung JM
Ann Transl Med; 2023 Jun; 11(9):309. PubMed ID: 37404988
[TBL] [Abstract][Full Text] [Related]
2. Zebrafish model of photochemical thrombosis for translational research and thrombolytic screening in vivo.
Lee IJ; Yang YC; Hsu JW; Chang WT; Chuang YJ; Liau I
J Biophotonics; 2017 Apr; 10(4):494-502. PubMed ID: 27174426
[TBL] [Abstract][Full Text] [Related]
3. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model.
Matsuno H; Uematsu T; Nagashima S; Nakashima M
J Pharmacol Methods; 1991 Jul; 25(4):303-17. PubMed ID: 1909407
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish (Danio rerio) Developed as an Alternative Animal Model for Focal Ischemic Stroke.
Yu X; Li YV
Acta Neurochir Suppl; 2016; 121():115-9. PubMed ID: 26463933
[TBL] [Abstract][Full Text] [Related]
5. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.
van Moorsel MVA; de Maat S; Vercruysse K; van Leeuwen EM; Jacqmarcq C; Bonnard T; Vivien D; van der Worp HB; Dijkhuizen RM; Maas C
Blood; 2022 Dec; 140(26):2844-2848. PubMed ID: 35960811
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Imaging of Cerebral Thromboemboli In Vivo: The Effects of Tissue-Type Plasminogen Activator.
Kim DE; Kim JY; Schellingerhout D; Ryu JH; Lee SK; Jeon S; Lee JS; Kim J; Jang HJ; Park JE; Kim EJ; Kwon IC; Ahn CH; Nahrendorf M; Kim K
Stroke; 2017 May; 48(5):1376-1385. PubMed ID: 28432262
[TBL] [Abstract][Full Text] [Related]
7. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy.
McCarthy JR; Sazonova IY; Erdem SS; Hara T; Thompson BD; Patel P; Botnaru I; Lin CP; Reed GL; Weissleder R; Jaffer FA
Nanomedicine (Lond); 2012 Jul; 7(7):1017-28. PubMed ID: 22348271
[TBL] [Abstract][Full Text] [Related]
9. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke.
Ma H; Jiang Z; Xu J; Liu J; Guo ZN
Drug Deliv; 2021 Dec; 28(1):357-371. PubMed ID: 33517820
[TBL] [Abstract][Full Text] [Related]
10. A canine coronary artery thrombosis model: application of photochemically induced thrombosis.
Umemura K; Ishiye M; Araki S; Nakashima M
Arch Int Pharmacodyn Ther; 1995; 330(1):13-24. PubMed ID: 8849307
[TBL] [Abstract][Full Text] [Related]
11. Potent Thrombolytic Effect of
Martinez de Lizarrondo S; Gakuba C; Herbig BA; Repessé Y; Ali C; Denis CV; Lenting PJ; Touzé E; Diamond SL; Vivien D; Gauberti M
Circulation; 2017 Aug; 136(7):646-660. PubMed ID: 28487393
[TBL] [Abstract][Full Text] [Related]
12. A Zebrafish Thrombosis Model for Assessing Antithrombotic Drugs.
Zhu XY; Liu HC; Guo SY; Xia B; Song RS; Lao QC; Xuan YX; Li CQ
Zebrafish; 2016 Aug; 13(4):335-44. PubMed ID: 27333081
[TBL] [Abstract][Full Text] [Related]
13. Selective Sphingosine 1-Phosphate Receptor 1 Modulation Augments Thrombolysis of Low-Dose Tissue Plasminogen Activator Following Cerebrovascular Thrombosis.
Li HD; Li R; Kong Y; Zhang W; Qi C; Wang D; Hao H; Liu Q
Front Immunol; 2022; 13():801727. PubMed ID: 35720286
[TBL] [Abstract][Full Text] [Related]
14. A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.
Huang Y; Jiang J; Ren J; Guo Y; Zhao Q; Zhou J; Li Y; Chen R
Adv Healthc Mater; 2022 Oct; 11(19):e2201265. PubMed ID: 35864062
[TBL] [Abstract][Full Text] [Related]
15. A novel platelet-rich arterial thrombosis model in rabbits. Simple, reproducible, and dynamic real-time measurement by using double-opposing inverted-sutures model.
Shieh SJ; Chiu HY; Shi GY; Wu CM; Wang JC; Chen CH; Wu HL
Thromb Res; 2001 Sep; 103(5):363-76. PubMed ID: 11553369
[TBL] [Abstract][Full Text] [Related]
16. Management of preterm infants with intracardiac thrombi: use of thrombolytic agents.
Rimensberger PC; Humbert JR; Beghetti M
Paediatr Drugs; 2001; 3(12):883-98. PubMed ID: 11772150
[TBL] [Abstract][Full Text] [Related]
17. Pre-existing Mobile Cardiac Thrombus and the Risk of Early Recurrent Embolism after Intravenous Thrombolysis: A Case Report.
Kobayashi M; Tanaka R; Yamashiro K; Ueno Y; Kato E; Miura S; Daida H; Hattori N
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):e161-3. PubMed ID: 25836630
[TBL] [Abstract][Full Text] [Related]
18. Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke.
Ducroux C; Di Meglio L; Loyau S; Delbosc S; Boisseau W; Deschildre C; Ben Maacha M; Blanc R; Redjem H; Ciccio G; Smajda S; Fahed R; Michel JB; Piotin M; Salomon L; Mazighi M; Ho-Tin-Noe B; Desilles JP
Stroke; 2018 Mar; 49(3):754-757. PubMed ID: 29438080
[TBL] [Abstract][Full Text] [Related]
19. Anti-thrombotic and pro-angiogenic effects of Rubia cordifolia extract in zebrafish.
Chen Y; Chen PD; Bao BH; Shan MQ; Zhang KC; Cheng FF; Cao YD; Zhang L; Ding AW
J Ethnopharmacol; 2018 Jun; 219():152-160. PubMed ID: 29126989
[TBL] [Abstract][Full Text] [Related]
20. Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator.
Matsuno H; Uematsu T; Umemura K; Takiguchi Y; Wada K; Nakashima M
Br J Pharmacol; 1992 Jul; 106(3):533-8. PubMed ID: 1387025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
